Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

Levosimendan was first approved for clinical use in 2000, when authorization was granted by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely decompensated chronic heart failure (HF). In the ensuing 20 years, this distinctive inodilator, which enhances cardiac...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Cardiovasc Pharmacol
Main Authors: Papp, Zoltán, Agostoni, Piergiuseppe, Alvarez, Julian, Bettex, Dominique, Bouchez, Stefan, Brito, Dulce, Černý, Vladimir, Comin-Colet, Josep, Crespo-Leiro, Marisa G., Delgado, Juan F., Édes, István, Eremenko, Alexander A., Farmakis, Dimitrios, Fedele, Francesco, Fonseca, Cândida, Fruhwald, Sonja, Girardis, Massimo, Guarracino, Fabio, Harjola, Veli-Pekka, Heringlake, Matthias, Herpain, Antoine, Heunks, Leo M. A., Husebye, Tryggve, Ivancan, Višnja, Karason, Kristjan, Kaul, Sundeep, Kivikko, Matti, Kubica, Janek, Masip, Josep, Matskeplishvili, Simon, Mebazaa, Alexandre, Nieminen, Markku S., Oliva, Fabrizio, Papp, Julius G., Parissis, John, Parkhomenko, Alexander, Põder, Pentti, Pölzl, Gerhard, Reinecke, Alexander, Ricksten, Sven-Erik, Riha, Hynek, Rudiger, Alain, Sarapohja, Toni, Schwinger, Robert H. G., Toller, Wolfgang, Tritapepe, Luigi, Tschöpe, Carsten, Wikström, Gerhard, von Lewinski, Dirk, Vrtovec, Bojan, Pollesello, Piero
Format: Artigo
Sprog:Inglês
Udgivet: Journal of Cardiovascular Pharmacology 2020
Fag:
Perspectives
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340234/
https://ncbi.nlm.nih.gov/pubmed/32639325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000859
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker